Vigil Neuroscience, Inc.

NasdaqGS:VIGL Stock Report

Market Cap: US$141.9m

Vigil Neuroscience Balance Sheet Health

Financial Health criteria checks 5/6

Vigil Neuroscience has a total shareholder equity of $85.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $108.5M and $23.2M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$86.67m
EquityUS$85.27m
Total liabilitiesUS$23.19m
Total assetsUS$108.46m

Recent financial health updates

Recent updates

We Think Vigil Neuroscience (NASDAQ:VIGL) Needs To Drive Business Growth Carefully

Oct 17
We Think Vigil Neuroscience (NASDAQ:VIGL) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Rate

May 30
We're Keeping An Eye On Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Rate

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Feb 01
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Oct 14
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Jun 27
Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Mar 14
Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Nov 29
Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Vigil draws bullish view at Wedbush on upcoming readout for lead asset

Sep 16

Vigil Neuroscience announces $75M PIPE financing

Aug 12

We're Hopeful That Vigil Neuroscience (NASDAQ:VIGL) Will Use Its Cash Wisely

Jul 25
We're Hopeful That Vigil Neuroscience (NASDAQ:VIGL) Will Use Its Cash Wisely

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Invest In Growth?

Apr 10
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Invest In Growth?

Financial Position Analysis

Short Term Liabilities: VIGL's short term assets ($90.2M) exceed its short term liabilities ($10.8M).

Long Term Liabilities: VIGL's short term assets ($90.2M) exceed its long term liabilities ($12.4M).


Debt to Equity History and Analysis

Debt Level: VIGL is debt free.

Reducing Debt: VIGL had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VIGL has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: VIGL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 25.7% each year


Discover healthy companies